Full Text View
Tabular View
No Study Results Posted
Related Studies
Quetiapine and the Dopaminergic Epigenetic Control
This study has been completed.
Study NCT00370500   Information provided by University of Erlangen-Nürnberg Medical School

First Received on August 30, 2006.   Last Updated on July 9, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Quetiapine fumarate
Additional drug interventions recognized in this trial
Dopamine
Dopamine Agents
Dopamine Agonists
Quetiapine
More general drug interventions related to this trial
Antipsychotic Agents
Autonomic Agents
Cardiotonic Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Psychotropic Drugs
Sympathomimetics
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
University of Erlangen-Nürnberg
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services